{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T18:43:43Z","timestamp":1772909023931,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"am","delay-in-days":378,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR000445"],"award-info":[{"award-number":["UL1TR000445"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association Inc","doi-asserted-by":"publisher","award":["929347"],"award-info":[{"award-number":["929347"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinejcf.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.cardfail.2023.09.015","type":"journal-article","created":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T23:08:56Z","timestamp":1698620936000},"page":"694-700","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Early Assessment of Cardiac Allograft Vasculopathy Risk Among Recipients of Hepatitis C Virus-infected Donors in the Current Era"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3379-5834","authenticated-orcid":false,"given":"KAUSHIK","family":"AMANCHERLA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"IRENE D.","family":"FEURER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SCOTT A.","family":"REGA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ANDREW","family":"CLUCKEY","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MOHAMED","family":"SALIH","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JONATHAN","family":"DAVIS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DAWN","family":"PEDROTTY","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HENRY","family":"OOI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ANIKET S.","family":"RALI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HASAN K.","family":"SIDDIQI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JONATHAN","family":"MENACHEM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DOUGLAS M.","family":"BRINKLEY","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LYNN","family":"PUNNOOSE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SUZANNE B.","family":"SACKS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SANDIP K.","family":"ZALAWADIYA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MARK","family":"WIGGER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KEKI","family":"BALSARA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JOHN","family":"TRAHANAS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"WILLIAM G.","family":"MCMASTER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JORDAN","family":"HOFFMAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CHETAN","family":"PASRIJA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JOANN","family":"LINDENFELD","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ASHISH S.","family":"SHAH","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KELLY H.","family":"SCHLENDORF","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cardfail.2023.09.015_bib0001","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/jamacardio.2019.4748","article-title":"Expanding heart transplant in the era of direct-acting antiviral therapy for hepatitis C","volume":"5","author":"Schlendorf","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cardfail.2023.09.015_bib0002","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.healun.2020.03.004","article-title":"Utilization of hepatitis C virus-infected organ donors in cardiothoracic transplantation: an ISHLT expert consensus statement","volume":"39","author":"Aslam","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cardfail.2023.09.015_bib0003","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/cid\/ciy585","article-title":"Hepatitis C guidance 2018 update: AASLD-IDSA recommendations for testing, managing, and treating hepatitis C virus infection","volume":"67","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cardfail.2023.09.015_bib0004","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.healun.2018.01.1293","article-title":"Early outcomes using hepatitis C-positive donors for cardiac transplantation in the era of effective direct-acting anti-viral therapies","volume":"37","author":"Schlendorf","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cardfail.2023.09.015_bib0005","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s40472-021-00350-1","article-title":"Hepatitis C positive organ donation in heart transplantation","volume":"8","author":"Siddiqi","year":"2021","journal-title":"Curr Transplant Rep"},{"key":"10.1016\/j.cardfail.2023.09.015_bib0006","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.healun.2019.08.019","article-title":"Outcomes of heart transplantation from hepatitis C virus-positive donors","volume":"38","author":"Aslam","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cardfail.2023.09.015_bib0007","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.healun.2011.04.008","article-title":"Diverse morphologic manifestations of cardiac allograft vasculopathy: a pathologic study of 64 allograft hearts","volume":"30","author":"Lu","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cardfail.2023.09.015_bib0008","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.healun.2006.05.009","article-title":"Assessment of cardiac allograft vasculopathy late after heart transplantation: when is coronary angiography necessary?","volume":"25","author":"Stork","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cardfail.2023.09.015_bib0009","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1161\/01.CIR.91.6.1706","article-title":"Occult and frequent transmission of atherosclerotic coronary disease with cardiac transplantation. Insights from intravascular ultrasound","volume":"91","author":"Tuzcu","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2023.09.015_bib0010","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.healun.2021.07.015","article-title":"The International thoracic organ transplant registry of the international society for heart and lung transplantation: Thirty-eighth Adult Heart Transplantation Report - 2021; focus on recipient characteristics","volume":"40","author":"Khush","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cardfail.2023.09.015_bib0011","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1161\/ATVBAHA.114.302818","article-title":"Interacting mechanisms in the pathogenesis of cardiac allograft vasculopathy","volume":"34","author":"Pober","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cardfail.2023.09.015_bib0012","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1161\/CIRCULATIONAHA.119.044924","article-title":"Identification and characterization of trajectories of cardiac allograft vasculopathy after heart transplantation: a population-based study","volume":"141","author":"Loupy","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2023.09.015_bib0013","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.jacc.2005.02.035","article-title":"Multicenter intravascular ultrasound validation study among heart transplant recipients: outcomes after five years","volume":"45","author":"Kobashigawa","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2023.09.015_bib0014","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.jacc.2004.12.076","article-title":"Intravascular ultrasound evidence of angiographically silent progression in coronary atherosclerosis predicts long-term morbidity and mortality after cardiac transplantation","volume":"45","author":"Tuzcu","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2023.09.015_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.cardfail.2023.09.015_bib0016","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.cardfail.2023.09.015_bib0017","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.healun.2010.05.017","article-title":"International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy\u20142010","volume":"29","author":"Mehra","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cardfail.2023.09.015_bib0018","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S1053-2498(03)00148-7","article-title":"Donor hepatitis-C seropositivity is an independent risk factor for the development of accelerated coronary vasculopathy and predicts outcome after cardiac transplantation","volume":"23","author":"Haji","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cardfail.2023.09.015_bib0019","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1001\/jama.296.15.1843","article-title":"Hepatitis C virus seropositivity in organ donors and survival in heart transplant recipients","volume":"296","author":"Gasink","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.cardfail.2023.09.015_bib0020","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","article-title":"Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial","volume":"358","author":"Manns","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.cardfail.2023.09.015_bib0021","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":"Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection","volume":"347","author":"Fried","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2023.09.015_bib0022","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1365-2125.2012.04373.x","article-title":"Effect of peginterferon alfa-2a (40KD) on cytochrome P450 isoenzyme activity","volume":"75","author":"Brennan","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.cardfail.2023.09.015_bib0023","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1056\/NEJMoa1402454","article-title":"Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection","volume":"370","author":"Afdhal","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2023.09.015_bib0024","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1056\/NEJMoa1512610","article-title":"Sofosbuvir and velpatasvir for HCV genotype 1, 2, 4, 5, and 6 infection","volume":"373","author":"Feld","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2023.09.015_bib0025","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1056\/NEJMoa1512614","article-title":"Sofosbuvir and velpatasvir for HCV in patients with decompensated cirrhosis","volume":"373","author":"Curry","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2023.09.015_bib0026","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.healun.2020.06.021","article-title":"Cardiac allograft vasculopathy and secondary outcomes of hepatitis C-positive donor hearts at 1 year after transplantation","volume":"39","author":"Madan","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cardfail.2023.09.015_bib0027","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1161\/CIRCULATIONAHA.105.597526","article-title":"The chemokine and chemokine receptor profile of infiltrating cells in the wall of arteries with cardiac allograft vasculopathy is indicative of a memory T-helper 1 response","volume":"114","author":"van Loosdregt","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2023.09.015_bib0028","first-page":"791","article-title":"Human coronary transplantation-associated arteriosclerosis. Evidence for a chronic immune reaction to activated graft endothelial cells","volume":"138","author":"Salomon","year":"1991","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cardfail.2023.09.015_bib0029","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/1471-2334-11-265","article-title":"Evaluation of endothelial function and subclinical atherosclerosis in association with hepatitis C virus in HIV-infected patients: a cross-sectional study","volume":"11","author":"Masia","year":"2011","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cardfail.2023.09.015_bib0030","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/682174","article-title":"Endothelial dysfunction correlates with liver fibrosis in chronic HCV infection","volume":"2015","author":"Barone","year":"2015","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.cardfail.2023.09.015_bib0031","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1097\/QAD.0b013e32833ce54d","article-title":"Hepatitis C virus infection is associated with endothelial dysfunction in HIV\/hepatitis C virus coinfected patients","volume":"24","author":"de Castro","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.cardfail.2023.09.015_bib0032","doi-asserted-by":"crossref","first-page":"ofz223","DOI":"10.1093\/ofid\/ofz223","article-title":"Observed changes in natural killer and T cell phenotypes with evaluation of immune outcome in a longitudinal cohort following sofosbuvir-based therapy for chronic hepatitis C infection","volume":"6","author":"Stevenson","year":"2019","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"10.1016\/j.cardfail.2023.09.015_bib0033","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.3390\/jcm9041030","article-title":"Immunomodulation of the natural killer cell phenotype and response during HCV infection","volume":"9","author":"Njiomegnie","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.cardfail.2023.09.015_bib0034","doi-asserted-by":"crossref","first-page":"19924","DOI":"10.1038\/s41598-020-77020-2","article-title":"Reconstitution of T follicular helper-humoral immune axis with elimination of hepatitis C virus","volume":"10","author":"Khanam","year":"2020","journal-title":"Sci Rep"},{"issue":"242","key":"10.1016\/j.cardfail.2023.09.015_bib0035","doi-asserted-by":"crossref","first-page":"242ra281","DOI":"10.1126\/scitranslmed.3008793","article-title":"HCV-induced immune responses influence the development of operational tolerance after liver transplantation in humans","volume":"6","author":"Bohne","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.cardfail.2023.09.015_bib0036","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2017.02.037","article-title":"Direct-acting antiviral therapy restores immune tolerance to patients with hepatitis C virus-induced cryoglobulinemia vasculitis","volume":"152","author":"Comarmond","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cardfail.2023.09.015_bib0037","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jhep.2005.11.047","article-title":"Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence","volume":"44","author":"Tisone","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.cardfail.2023.09.015_bib0038","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1111\/ajt.17190","article-title":"Long-term follow-up of acute and chronic rejection in heart transplant recipients from hepatitis C viremic (NAT+) donors","volume":"22","author":"Stachel","year":"2022","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cardfail.2023.09.015_bib0039","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.healun.2020.06.022","article-title":"Increased early acute cellular rejection events in hepatitis C-positive heart transplantation","volume":"39","author":"Gidea","year":"2020","journal-title":"J Heart Lung Transplant"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916423003810?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916423003810?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T12:42:22Z","timestamp":1728909742000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071916423003810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S1071916423003810"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2023.09.015","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early Assessment of Cardiac Allograft Vasculopathy Risk Among Recipients of Hepatitis C Virus-infected Donors in the Current Era","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiac Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cardfail.2023.09.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}